Quanterix Corporation (QTRX) Sets All-Time Low at $13.95

June 29, 2018 - By Glen Chin

On Jun, 29, all time low was touched by Quanterix Corporation (NASDAQ:QTRX). Today’s share price was $13.95. It’s 4.00 % below our $13.39. Barchart.com reported this technical pattern. Quanterix Corporation (NASDAQ:QTRX) has $306.34 million MC. At $13.39 stock target, the company valuation changes by $12.25 million less.

Ticker’s shares touched $13.95 during the last trading session after 0.92% change.Currently Quanterix Corporation is after 0.00% change in last June 29, 2017. QTRX has also 46,443 shares volume. The stock underperformed the S&P500 by 12.57%.

Quanterix Corporation (NASDAQ:QTRX)’s quarterly earnings will be announced on August, 21., RTT reports. After $-0.33 EPS report last quarter, Wall Street now predicts -15.15 % EPS growth of Quanterix Corporation.

For more Quanterix Corporation (NASDAQ:QTRX) news released recently go to: Seekingalpha.com, Benzinga.com, Benzinga.com, Businesswire.com or Benzinga.com. The titles are as follows: “Stocks To Watch: Eyes On Apple’s WWDC, SCOTUS And DC” released on June 02, 2018, “45 Biggest Movers From Yesterday” on June 06, 2018, “The Week Ahead: Apple’s Developer Conference In The Spotlight, ASCO Meeting Could Move Biotechs” with a publish date: June 04, 2018, “EY Announces Kevin Hrusovsky, President, Chairman and Chief Executive Officer of Quanterix and Founder of …” and the last “35 Stocks Moving In Tuesday’s Mid-Day Session” with publication date: June 05, 2018.

Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and Asia Pacific.The company has $306.34 million market cap. It develops Simoa HD-1 Analyzer, a sensitive protein detection platform, which analyzes approximately six biomarkers per test; and SR-X system that supports the detection capability of approximately six biomarkers per test.Currently it has negative earnings. The company's products also comprise kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips.

Quanterix Corporation (NASDAQ:QTRX) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.